Osteoporosis is a metabolic bone disease primarily caused by a decreased bone formation and increased bone resorption. Osteoclasts are a special class of terminally differentiated cells that play an important role in normal bone remodeling and bone loss in osteoporosis as well as in a variety of osteolytic diseases. Osteoclasts can be differentiated from monocyte–macrophage cells of the hematopoietic system; they are the key cells in bone resorption. Osteoclast formation and differentiation are regulated by various cytokines and transcription factors. In this review, we summarize recent advances in research on the regulation of osteoclast differentiation and function by factors such as M‐CSF, RANKL, AP‐1, NFATC1, MITF, and PU.1. Understanding these cytokines and transcription factors can not only help identify targets for osteoclast differentiation but also aid in intervening in the treatment of osteoclast‐related diseases.
Unraveling the Mechanisms That Regulate Osteoclast Differentiation: A Review of Current Advances
Sai Zhang,Meng Gao,Shuzhe Song,Tongdan Zhao,Bianhua Zhou,Hongwei Wang,Weishun Tian,Wenpeng Zhao,Jing-hong Zhao
Published 2025 in Genesis
ABSTRACT
PUBLICATION RECORD
- Publication year
2025
- Venue
Genesis
- Publication date
2025-02-01
- Fields of study
Biology, Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.